[ENZYME THERAPY OF POSTCHOLECYSTECTOMY SYNDROME IN CHILDREN].
The article provides pathogenetic justification of the need and the effectiveness of enzyme replacement therapy (ERT) of postcholecystectomy syndrome (PHES) in children. Special focus will be on the possibility of using the ERT in PHES in children of different age groups. Personal experience with these drugs in children with cholelithiasis is provided, considering their mechanism of action and side effects of ERT. Advantages of Creon are demonstrated for correction of exocrine pancreatic function in PHES in children.
L A
LA
Kharitonova
R R
RR
Kuramshin
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D056947:Enzyme Replacement Therapy; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D020799:Pancrelipase / Q000627:therapeutic use*; D017562:Postcholecystectomy Syndrome / Q000188:drug therapy* / Q000201:enzymology
D005765:Gastrointestinal Agents; D020799:Pancrelipase